CJ-12255

• Description :

  CJ-12255 is a selective NK1-R antagonist. CJ-12255 has no affinity for the NK-2 or NK-3 receptors. CJ-12255 blocks an substance P (SP) -induced chronic ulcerative colitis (CUC) in rats. CJ-12255 also reduces intraabdominal adhesion formation during abdominal surgery in rats[1][2].

• UNSPSC :

  12352005

• Target :

  Neurokinin Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Inflammation/Immunology

• Smiles :

  O=C([C@H]1C[N@@]2[C@@H](C(C3=CC=CC=C3)C4=CC=CC=C4)[C@@H](NCC5=CC(C(C)C)=CC=C5OC)[C@@]1([H])CC2)O

• Molecular Formula :

  C32H38N2O3

• Molecular Weight :

  498.66

• References & Citations :

  [1]Stucchi AF, wt al. A neurokinin 1 receptor antagonist reduces an ongoing ileal pouch inflammation and the response to a subsequent inflammatory stimulus. Am J Physiol Gastrointest Liver Physiol. 2003 Dec;285 (6) :G1259-67. |[2]Cohen PA, et al. A neurokinin-1 receptor antagonist that reduces intraabdominal adhesion formation increases peritoneal matrix metalloproteinase activity. Wound Repair Regen. 2007 Nov-Dec;15 (6) :800-8.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  Phase 1

• Isoform :

  NK1R

• CAS Number :

  [146725-78-2]